BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36697096)

  • 21. Immunocytochemical staining of cells in 153 pleural effusions with a panel of monoclonal antibodies and lectins.
    Abramenko IV; Gluzman DF; Sklyarenko LM; Pisnyachevskaya GV; Pinchouk VG
    Anticancer Res; 1991; 11(2):629-34. PubMed ID: 1712178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
    Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
    Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma.
    Patel A; Borczuk AC; Siddiqui MT
    J Am Soc Cytopathol; 2020; 9(3):146-151. PubMed ID: 32184064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differential diagnosis of pleural effusions].
    Ogino M; Koike K; Satoh K; Arai K
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
    Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
    Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.
    Elmas H; Biancosino C; Önal B; Schmitt F; Buyucek S; Nordholt G; Sauter G; Welker L
    Adv Exp Med Biol; 2022; 1374():51-62. PubMed ID: 35147931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
    Kuralay F; Tokgöz Z; Cömlekci A
    Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 30. The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.
    Ryu JS; Lee HJ; Cho JH; Han HS; Lee HL
    Respirology; 2003 Dec; 8(4):487-91. PubMed ID: 14629653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cytoblock on pleural effusion for diagnosis of malignant disease.
    Shahini L; Hoxha M; Marku F; Morina B; Cena V; Kabashi K; Mustafa L
    Diagn Cytopathol; 2023 Nov; 51(11):684-688. PubMed ID: 37547992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological markers of chromosomal instability as predictors of malignancy in pleural effusion.
    Aggarwal P; Handa U; Bhagat R; Aggarwal D
    Diagn Cytopathol; 2024 Feb; 52(2):76-81. PubMed ID: 37946685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of flow cytometry in the diagnostic work up of malignant effusions due to nonhematopoietic neoplasms.
    Wong-Arteta J; Rey M; Aragón L; Gil-Rodríguez E; Bujanda L
    Cytometry B Clin Cytom; 2020 Nov; 98(6):504-515. PubMed ID: 32506689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
    Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
    Liao ND; Chiang TA; Lee WY
    Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.
    Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S
    Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
    Khurram N; Anis T; Yusuf NW
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.